Abstract 362P
Background
Continuity of care is an important domain of provision of Palliative services. Round the clock Consultation liaison services are provided to all registered Patients (through an on-call number manned by the Resident on call). The Investigator's phone number is bieng provided upon Patient request. Advice regarding symptomatic management (including titration of analgesia), counseling regarding goals of care and opportunity to facilitate a liaison with the Patient's Local physician are bieng provided via telephonic consult. Text messages also form a frequent means of providing important treatment related information.
Methods
29 patients who had contacted this Resident during a period extending from November 2017 to May 2019 were invited to take part in an Investigator initiated Telephonic survey.
Results
11 respondents who were also primary caregivers agreed to participate. The remainder either were unreachable or declined to participate. 5/11 respondents had contacted the on call number while 7/11 had contacted the Investigator's number more than twice. 4/7 were satisfied with the response that they received on the on call number. 2 out of 10 respondents had used the number facilitating a liaison between the Resident and Local Physician. There was unanimous agreement on the feasibility and appropriateness of the on call liaison for provision of Bereavement services. There was consensus that the gender of the Resident did not affect Patient preferences. All respondents agreed that the text message had been an important means of disseminating information. Difficult to control pain was identified as the leading indication for seeking a Telephonic liaison. 3/11 respondents opined that the on-call number should be more accessible. 5/7 respondents agreed that they could have been provided better end of life care. Pain, reduced oral intake and constipation were identified as symptoms that caused the maximum amount of concern during the terminal phase of decline. Two caregivers used the opportunity to air grievances about quality of patient care services that they were provided.
Conclusions
Telephonic liaison services have the potential to act as an effective mode of delivery of palliative (including end of life care) services.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Dr. Rahul D. Arora, Senior Resident, Dept. of Palliative Medicine, All India Institute of Medical Scinces, New Delhi, India.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
117P - Short-term and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for multiple colorectal liver metastases: A propensity score matching study
Presenter: Wenbai Huang
Session: Poster display session
Resources:
Abstract
119P - The impacts of dose-time-fractionation schedules on pathological complete response rate (pCR) and local recurrence (LR)
Presenter: Fu Jin
Session: Poster display session
Resources:
Abstract
120P - Platelet to lymphocyte ratio is associated with tumour localization and outcomes in patients with metastatic colorectal cancer
Presenter: Ahmet Bilici
Session: Poster display session
Resources:
Abstract
121P - Meta-analysis of three-dimensional versus two-dimensional laparoscopic surgery for rectal cancer
Presenter: Laiyuan Li
Session: Poster display session
Resources:
Abstract
127P - Outcomes based on albumin‐bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
Presenter: Stephen Chan
Session: Poster display session
Resources:
Abstract
128P - Tislelizumab in combination with chemotherapy for Chinese patients (Pts) with gastric/gastroesophageal junction cancer (GC/GEJC) or esophageal squamous cell carcinoma (ESCC)
Presenter: Yuxian Bai
Session: Poster display session
Resources:
Abstract
129P - Monitoring patient-specific mutation in ctDNA and CTC for tumour response evaluation after neoadjuvant chemotherapy in advanced gastric adenocarcinoma (NCT03425058)
Presenter: Tao Fu
Session: Poster display session
Resources:
Abstract
130P - Development of a liver cancer risk prediction model for the general population in china: A potential tool for screening
Presenter: Xiaoshuang Feng
Session: Poster display session
Resources:
Abstract
131P - Cabozantinib in Asian patients with hepatocellular carcinoma and other solid tumours: Population pharmacokinetics analysis
Presenter: Chih-Hung Hsu
Session: Poster display session
Resources:
Abstract
132P - Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC)
Presenter: Tatsuya Ioka
Session: Poster display session
Resources:
Abstract